Principal Financial Group Inc Compass Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$1.0 - $1.85 $586 - $1,084
-586 Reduced 5.54%
10,000 $10,000
Q1 2024

Apr 29, 2024
SELL
$1.2 - $2.29 $1,663 - $3,173
-1,386 Reduced 11.58%
10,586 $20,000
Q3 2023

Nov 02, 2023
BUY
$1.87 - $3.25 $22,387 - $38,909
11,972 New
11,972 $23,000

Others Institutions Holding CMPX

# of Institutions
80
Shares Held
92M
Call Options Held
0
Put Options Held
0
View Full List

About Compass Therapeutics, Inc.

CMPX Quotes by TradingView
  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $161M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email